Kovacs GG. Invited review: neuropathology of tauopathies: principles and practice. Neuropathol Appl Neurobiol. 2015;41(1):3–23.
Article
CAS
PubMed
Google Scholar
Ghetti B, Oblak AL, Boeve BF, Johnson KA, Dickerson BC, Goedert M. Invited review: frontotemporal dementia caused by microtubule-associated protein tau gene (MAPT) mutations: a chameleon for neuropathology and neuroimaging. Neuropathol Appl Neurobiol. 2015;41(1):24–46. A published correction appears in Neuropathol Appl Neurobiol. 2015;41(4):571.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hirschbichler ST, Erro R, Batla A, Bhatia KP. Classic PD-like rest tremor associated with the tau p.R406W mutation. Parkinsonism Relat Disord. 2015;21(8):1002–4.
Article
PubMed
Google Scholar
Lindquist SG, Holm IE, Schwartz M, Law I, Stokholm J, Batbayli M, et al. Alzheimer disease-like clinical phenotype in a family with FTDP-17 caused by a MAPT R406W mutation. Eur J Neurol. 2008;15(4):377–85.
Article
CAS
PubMed
Google Scholar
Rosso SM, Kamphorst W, Ravid R, van Swieten JC. Coexistent tau and amyloid pathology in hereditary frontotemporal dementia with tau mutations. Ann N Y Acad Sci. 2000;920:115–9.
Article
CAS
PubMed
Google Scholar
Ishida C, Kobayashi K, Kitamura T, Ujike H, Iwasa K, Yamada M. Frontotemporal dementia with parkinsonism linked to chromosome 17 with the MAPT R406W mutation presenting with a broad distribution of abundant senile plaques. Neuropathology. 2015;35(1):75–82.
Article
CAS
PubMed
Google Scholar
Scheltens P, Fox N, Barkhof F, De Carli C. Structural magnetic resonance imaging in the practical assessment of dementia: beyond exclusion. Lancet Neurol. 2002;1(1):13–21.
Article
PubMed
Google Scholar
Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. AJR Am J Roentgenol. 1987;149(2):351–6.
Article
CAS
PubMed
Google Scholar
Smith R, Puschmann A, Scholl M, Ohlsson T, van Swieten J, Honer M, et al. 18F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in MAPT mutation carriers. Brain. 2016;139(Pt 9):2372–9.
Article
PubMed
PubMed Central
Google Scholar
Reed LA, Grabowski TJ, Schmidt ML, Morris JC, Goate A, Solodkin A, et al. Autosomal dominant dementia with widespread neurofibrillary tangles. Ann Neurol. 1997;42(4):564–72.
Article
CAS
PubMed
Google Scholar
Carney RM, Kohli MA, Kunkle BW, Naj AC, Gilbert JR, Zuchner S, et al. Parkinsonism and distinct dementia patterns in a family with the MAPT R406W mutation. Alzheimers Dement. 2014;10(3):360–5.
Article
PubMed
Google Scholar
Tolboom N, Koedam EL, Schott JM, Yaqub M, Blankenstein MA, Barkhof F, et al. Dementia mimicking Alzheimer’s disease owing to a tau mutation: CSF and PET findings. Alzheimer Dis Assoc Disord. 2010;24(3):303–7.
PubMed
Google Scholar
Ng AS, Sias AC, Pressman PS, Fong JC, Karydas AM, Zanto TP, et al. Young-onset frontotemporal dementia in a homozygous tau R406W mutation carrier. Ann Clin Transl Neurol. 2015;2(12):1124–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Behnam M, Ghorbani F, Shin JH, Kim DS, Jang H, Nouri N, et al. Homozygous MAPT R406W mutation causing FTDP phenotype: a unique instance of a unique mutation. Gene. 2015;570(1):150–2.
Article
CAS
PubMed
Google Scholar
Ygland E, Taroni F, Gellera C, Caldarazzo S, Duno M, Soller M, et al. Atypical Friedreich ataxia in patients with FXN p.R165P point mutation or comorbid hemochromatosis. Parkinsonism Relat Disord. 2014;20(8):919–23.
Article
PubMed
Google Scholar
Moulin CJ. Disordered recognition memory: recollective confabulation. Cortex. 2013;49(6):1541–52.
Article
PubMed
Google Scholar
Wood R, Moodley K, Hodges JR, Allinson K, Spillantini MG, Chan D. Slowly progressive behavioural presentation in two UK cases with the R406W MAPT mutation. Neuropathol Appl Neurobiol. 2016;42(3):291–5.
Article
CAS
PubMed
Google Scholar
Davies RR, Halliday GM, Xuereb JH, Kril JJ, Hodges JR. The neural basis of semantic memory: evidence from semantic dementia. Neurobiol Aging. 2009;30(12):2043–52.
Article
PubMed
Google Scholar
van Swieten JC, Stevens M, Rosso SM, Rizzu P, Joosse M, de Koning I, et al. Phenotypic variation in hereditary frontotemporal dementia with tau mutations. Ann Neurol. 1999;46(4):617–26.
Article
PubMed
Google Scholar
Pickering-Brown SM, Rollinson S, Du Plessis D, Morrison KE, Varma A, Richardson AM, et al. Frequency and clinical characteristics of progranulin mutation carriers in the Manchester frontotemporal lobar degeneration cohort: comparison with patients with MAPT and no known mutations. Brain. 2008;131(Pt 3):721–31.
Article
PubMed
Google Scholar
Whitwell JL, Jack Jr CR, Boeve BF, Senjem ML, Baker M, Ivnik RJ, et al. Atrophy patterns in IVS10 + 16, IVS10 + 3, N279K, S305N, P301L, and V337M MAPT mutations. Neurology. 2009;73(13):1058–65.
Article
CAS
PubMed
PubMed Central
Google Scholar
Dickson DW, Ahmed Z, Algom AA, Tsuboi Y, Josephs KA. Neuropathology of variants of progressive supranuclear palsy. Curr Opin Neurol. 2010;23(4):394–400.
Article
PubMed
Google Scholar
Kovacs GG, Ferrer I, Grinberg LT, Alafuzoff I, Attems J, Budka H, et al. Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy. Acta Neuropathol. 2016;131(1):87–102.
Article
CAS
PubMed
Google Scholar
Fujioka S, Sanchez Contreras MY, Strongosky AJ, Ogaki K, Whaley NR, Tacik PM, et al. Three sib-pairs of autopsy-confirmed progressive supranuclear palsy. Parkinsonism Relat Disord. 2015;21(2):101–5.
Article
PubMed
Google Scholar
Myers AJ, Pittman AM, Zhao AS, Rohrer K, Kaleem M, Marlowe L, et al. The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts. Neurobiol Dis. 2007;25(3):561–70.
Article
CAS
PubMed
Google Scholar
Rademakers R, Melquist S, Cruts M, Theuns J, Del-Favero J, Poorkaj P, et al. High-density SNP haplotyping suggests altered regulation of tau gene expression in progressive supranuclear palsy. Hum Mol Genet. 2005;14(21):3281–92.
Article
CAS
PubMed
Google Scholar
Yokoyama JS, Karch CM, Fan CC, Bonham LW, Kouri N, Ross OA, et al. Shared genetic risk between corticobasal degeneration, progressive supranuclear palsy, and frontotemporal dementia. Acta Neuropathol. 2017;133(5):825–37.
Article
CAS
PubMed
PubMed Central
Google Scholar
Baba Y, Tsuboi Y, Baker MC, Uitti RJ, Hutton ML, Dickson DW, et al. The effect of tau genotype on clinical features in FTDP-17. Parkinsonism Relat Disord. 2005;11(4):205–8.
Article
PubMed
Google Scholar
Josephs KA, Mandrekar JN, Dickson DW. The relationship between histopathological features of progressive supranuclear palsy and disease duration. Parkinsonism Relat Disord. 2006;12(2):109–12.
Article
PubMed
Google Scholar
Hara M, Hirokawa K, Kamei S, Uchihara T. Isoform transition from four-repeat to three-repeat tau underlies dendrosomatic and regional progression of neurofibrillary pathology. Acta Neuropathol. 2013;125(4):565–79.
Article
CAS
PubMed
Google Scholar
Miyasaka T, Morishima-Kawashima M, Ravid R, Heutink P, van Swieten JC, Nagashima K, et al. Molecular analysis of mutant and wild-type tau deposited in the brain affected by the FTDP-17 R406W mutation. Am J Pathol. 2001;158(2):373–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hong M, Zhukareva V, Vogelsberg-Ragaglia V, Wszolek Z, Reed L, Miller BI, et al. Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. Science. 1998;282(5395):1914–7.
Article
CAS
PubMed
Google Scholar
de Silva R, Lashley T, Strand C, Shiarli AM, Shi J, Tian J, et al. An immunohistochemical study of cases of sporadic and inherited frontotemporal lobar degeneration using 3R- and 4R-specific tau monoclonal antibodies. Acta Neuropathol. 2006;111(4):329–40.
Article
PubMed
Google Scholar
Reed LA, Wszolek ZK, Hutton M. Phenotypic correlations in FTDP-17. Neurobiol Aging. 2001;22(1):89–107.
Article
CAS
PubMed
Google Scholar
Mott RT, Dickson DW, Trojanowski JQ, Zhukareva V, Lee VM, Forman M, et al. Neuropathologic, biochemical, and molecular characterization of the frontotemporal dementias. J Neuropathol Exp Neurol. 2005;64(5):420–8.
Article
CAS
PubMed
Google Scholar
Tackenberg C, Brandt R. Divergent pathways mediate spine alterations and cell death induced by amyloid-β, wild-type tau, and R406W tau. J Neurosci. 2009;29(46):14439–50.
Article
CAS
PubMed
Google Scholar
Braak H, Del Tredici K. The preclinical phase of the pathological process underlying sporadic Alzheimer’s disease. Brain. 2015;138(Pt 10):2814–33.
Article
PubMed
Google Scholar
Vitali A, Piccini A, Borghi R, Fornaro P, Siedlak SL, Smith MA, et al. Soluble amyloid β-protein is increased in frontotemporal dementia with tau gene mutations. J Alzheimers Dis. 2004;6(1):45–51.
Article
CAS
PubMed
Google Scholar
Crary JF, Trojanowski JQ, Schneider JA, Abisambra JF, Abner EL, Alafuzoff I, et al. Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathol. 2014;128(6):755–66.
Article
CAS
PubMed
PubMed Central
Google Scholar
Duyckaerts C, Braak H, Brion JP, Buee L, Del Tredici K, Goedert M, et al. PART is part of Alzheimer disease. Acta Neuropathol. 2015;129(5):749–56.
Article
CAS
PubMed
PubMed Central
Google Scholar
Jellinger KA, Alafuzoff I, Attems J, Beach TG, Cairns NJ, Crary JF, et al. PART, a distinct tauopathy, different from classical sporadic Alzheimer disease. Acta Neuropathol. 2015;129(5):757–62.
Article
PubMed
PubMed Central
Google Scholar
Passant U, Ostojic J, Froelich Fabre S, Gustafson L, Lannfelt L, Larsson EM, et al. Familial presenile dementia with bitemporal atrophy. Dement Geriatr Cogn Disord. 2004;17(4):287–92.
Article
PubMed
Google Scholar
Ikeuchi T, Imamura T, Kawase Y, Kitade Y, Tsuchiya M, Tokutake T, et al. Evidence for a common founder and clinical characteristics of Japanese families with the MAPT R406W mutation. Dement Geriatr Cogn Dis Extra. 2011;1(1):267–75.
Article
PubMed
PubMed Central
Google Scholar
Komatsu J, Ono K, Yanase D, Samuraki M, Shima K, Kuwano R, et al. Imaging findings of familial dementia with a tau R406W mutation. Acta Neurol Belg. 2011;111(4):374–5.
PubMed
Google Scholar
Rizzu P, Van Swieten JC, Joosse M, Hasegawa M, Stevens M, Tibben A, et al. High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands. Am J Hum Genet. 1999;64(2):414–21.
Article
CAS
PubMed
PubMed Central
Google Scholar
Saito Y, Geyer A, Sasaki R, Kuzuhara S, Nanba E, Miyasaka T, et al. Early-onset, rapidly progressive familial tauopathy with R406W mutation. Neurology. 2002;58(5):811–3.
Article
CAS
PubMed
Google Scholar
Ostojic J, Elfgren C, Passant U, Nilsson K, Gustafson L, Lannfelt L, et al. The tau R406W mutation causes progressive presenile dementia with bitemporal atrophy. Dement Geriatr Cogn Disord. 2004;17(4):298–301.
Article
CAS
PubMed
Google Scholar
Basiri K, Ansari B, Meamar R. Frontotemporal dementia parkinsonism: clinical findings in a large Iranian family. Adv Biomed Res. 2015;4:37.
Article
PubMed
PubMed Central
Google Scholar
Wojtas A, Heggeli KA, Finch N, Baker M, Dejesus-Hernandez M, Younkin SG, et al. C9ORF72 repeat expansions and other FTD gene mutations in a clinical AD patient series from mayo clinic. Am J Neurodegener Dis. 2012;1(1):107–18.
PubMed
PubMed Central
Google Scholar
Ikeuchi T, Kaneko H, Miyashita A, Nozaki H, Kasuga K, Tsukie T, et al. Mutational analysis in early-onset familial dementia in the Japanese population: the role of PSEN1 and MAPT R406W mutations. Dement Geriatr Cogn Disord. 2008;26(1):43–9.
Article
CAS
PubMed
Google Scholar
Kitade Y, Sato A, Imamura T. Two sibling patients with Alzheimer’s disease associated with presenile onset and very slowly progressive clinical course. Jpn J Neuropsychol. 2006;22:260–8.
Google Scholar
Rademakers R, Dermaut B, Peeters K, Cruts M, Heutink P, Goate A, et al. Tau (MAPT) mutation Arg406Trp presenting clinically with Alzheimer disease does not share a common founder in Western Europe. Hum Mutat. 2003;22(5):409–11.
Article
CAS
PubMed
Google Scholar
Perry DC, Whitwell JL, Boeve BF, Pankratz VS, Knopman DS, Petersen RC, et al. Voxel-based morphometry in patients with obsessive-compulsive behaviors in behavioral variant frontotemporal dementia. Eur J Neurol. 2012;19(6):911–7.
Article
CAS
PubMed
PubMed Central
Google Scholar